Dual Role of p21 in the Progression of Cancer and Its Treatment
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Parveen, Amna | - |
dc.contributor.author | Akash, Muhammad Sajid Hamid | - |
dc.contributor.author | Rehman, Kanwal | - |
dc.contributor.author | Kyunn, Whang Wan | - |
dc.date.available | 2019-03-08T15:57:50Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1045-4403 | - |
dc.identifier.issn | 2162-6502 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/8685 | - |
dc.description.abstract | Cancer develops due to an imbalance between cell proliferation and cell death. Various mechanisms of carcinogenesis as well as of novel anticancer agents that could be targeted for the treatment of cancer have been proposed by different studies. Among these, p21 is recognized as a potent cyclin-dependent kinase inhibitor that facilitates cell-cycle arrest by interacting with different stimuli such as p53, DNA repair process, CDK, E2F1, MYC, PCNA, STAT3 AP4, proteasomes, K1F, CDX2, and ER-alpha. p21 acts both as a tumor-suppressor gene and an inhibitor of apoptosis by interacting with various molecules and transition factors. In this review, we discuss the complex role of p21 in the development of cancer and as a target in its treatment. We conclude that, in the future, the tumor-suppressor activity of p21 should be the focus of a novel treatment strategies, which may lead to the devolvement of new and selective anti-cancer agents for the targeted therapy of cancers. | - |
dc.format.extent | 14 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | BEGELL HOUSE INC | - |
dc.title | Dual Role of p21 in the Progression of Cancer and Its Treatment | - |
dc.type | Article | - |
dc.identifier.doi | 10.1615/CritRevEukaryotGeneExpr.v26.i1.60 | - |
dc.identifier.bibliographicCitation | CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION, v.26, no.1, pp 49 - 62 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000375749200006 | - |
dc.identifier.scopusid | 2-s2.0-84959191210 | - |
dc.citation.endPage | 62 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 49 | - |
dc.citation.title | CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | - |
dc.citation.volume | 26 | - |
dc.type.docType | Article | - |
dc.publisher.location | 미국 | - |
dc.subject.keywordAuthor | p21 | - |
dc.subject.keywordAuthor | p53 | - |
dc.subject.keywordAuthor | cancer treatment | - |
dc.subject.keywordAuthor | cyclin-dependent kinases | - |
dc.subject.keywordPlus | CELL-CYCLE ARREST | - |
dc.subject.keywordPlus | TUMOR-SUPPRESSOR GENE | - |
dc.subject.keywordPlus | KRUPPEL-LIKE FACTOR-6 | - |
dc.subject.keywordPlus | ESTROGEN-RECEPTOR-ALPHA | - |
dc.subject.keywordPlus | REG-GAMMA-PROTEASOME | - |
dc.subject.keywordPlus | PROSTATE-CANCER | - |
dc.subject.keywordPlus | BREAST-CANCER | - |
dc.subject.keywordPlus | C-MYC | - |
dc.subject.keywordPlus | UV-IRRADIATION | - |
dc.subject.keywordPlus | TRANSCRIPTION FACTOR | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Genetics & Heredity | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Genetics & Heredity | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.